FDA RECALL Brand: Aisling Product: DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL Issue: Presence of glass particles Date: 05/13/2026 More: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sun-pharmaceutical-industries-inc-sun-pharma-initiates-voluntary-us-nationwide-recall-doxorubicin #FDA #recall